Endoscopic Submucosal Dissection for Gastrointestinal Neoplasms

Status Recruiting

Clinical Trial Summary

Endoscopic submucosal dissection (ESD) is a newly developed technique in the field of endoscopic treatment for GI neoplasms, because of its high rate of en bloc resection. The purpose of this study is to evaluate the efficacy and safety of ESD for GI neoplasms.

Clinical Trial Description

Endoscopic mucosal resection (EMR) is widely accepted as a minimally invasive treatment for GI neoplasms.However, one disadvantage of EMR is that lesions larger than 2 cm in diameter must be removed in pieces, which may result in a high recurrence rate of residual tumor tissue. In addition, in most patients, pathological assessment cannot be conducted after the procedure. ESD can overcome the disadvantages of EMR. However, it is difficult to perform ESD for GI neoplasms because of the high rate of complications. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01378507
Study type	Interventional
Source	Chinese PLA General Hospital
Contact	Zhong-Sheng Lu, M.D.
Phone	86-10-66937467
Email	lzs936150@sohu.com
Status	Recruiting
Phase	N/A
Start date	January 2009
Completion date	April 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05294107` - Intestinal Organoids	N/A
Completed	`NCT02503696` - Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)	N/A
Completed	`NCT01427725` - Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
Completed	`NCT00210249` - Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
Active, not recruiting	`NCT05602935` - Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study	Phase 2
Completed	`NCT03614039` - Effect of Probiotic and Smectite Gel on NAFLD	N/A
Completed	`NCT03717298` - Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma	Phase 2
Recruiting	`NCT05322486` - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Terminated	`NCT02503631` - Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Completed	`NCT02267681` - Opioid Effects on Cognitive Function Following Colonoscopy	Phase 4
Completed	`NCT01600209` - Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing	N/A
Completed	`NCT01260168` - Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies	N/A
Active, not recruiting	`NCT01037049` - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks	Phase 2
Completed	`NCT03656744` - A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)	Phase 2
Completed	`NCT01463319` - Warm Water and Unsedated Colonoscopy	Phase 0
Terminated	`NCT00577772` - Transit Time and Bacterial Overgrowth Using SmartPill Capsule	N/A
Suspended	`NCT00606788` - Therapy Study of Automated Protocolized vs. Physician-Directed Non-Protocolized Weaning	N/A
Completed	`NCT04080843` - Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients	Phase 2
Recruiting	`NCT03776760` - Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination
Terminated	`NCT04644315` - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors	Phase 2